Risk factors

Onconetix (ONCO) risk factors

Item 1A of every Onconetix, Inc. 10-K on file, and what changed from one year to the next.

Open ONCO in Gloomberb →
  • FY2025 10-K risk factors

    91 risks, 9 new, 8 dropped, 11 reworded since the prior year. Onconetix pivoted its strategy by abandoning ENTADFI commercialization, settling its Veru debt, and pursuing the Realbotix transactions.

    Filed Mar 13, 2026
  • FY2024 10-K risk factors

    90 risks. Company faces severe going concern doubt with only $0.6 million in cash against $18.3 million in current liabilities. Operations rely heavily on single products like Proclarix and ENTADFI, and key partners like LabCorp and Veru.

    Filed Jun 02, 2025